mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.3 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.071 |
0.3 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.3 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |